Everolimus in Heart Transplantation: An Update
The evidence base relating to the use of everolimus in heart transplantation has expanded considerably in recent years, providing clinically relevant information regarding its use in clinical practice. Unless there are special considerations to take into account, all de novo heart transplant patient...
Saved in:
Main Authors: | Stephan W. Hirt, Christoph Bara, Markus J. Barten, Tobias Deuse, Andreas O. Doesch, Ingo Kaczmarek, Uwe Schulz, Jörg Stypmann, Assad Haneya, Hans B. Lehmkuhl |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2013/683964 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
by: Andreas Zuckermann, et al.
Published: (2011-01-01) -
Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage
by: Paul Gonzales, et al.
Published: (2017-01-01) -
Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01) -
Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
by: Laura Eibenschutz, et al.
Published: (2013-01-01) -
Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01)